Biomarin Pharmaceutical (BMRN) Current Assets (2009 - 2026)
Biomarin Pharmaceutical (BMRN) recorded Current Assets of $3.97 billion in Q2 2026, up 4.4% from $3.81 billion a year earlier but down 13.8% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Biomarin Pharmaceutical reported Current Assets of $3.95 billion, up 22.3% from FY2024.
- Annual Current Assets has increased for four straight years, with a five-year compound annual growth rate of 11.0% (FY2020 to FY2025).
- Across earlier years, Current Assets came in at $3.23 billion in FY2024 (+9.3%), $2.96 billion in FY2023 (+7.4%), $2.75 billion in FY2022 (+21.0%) and $2.27 billion in FY2021 (-2.9%).
- Quarterly Current Assets has ranged from $2.27 billion in Q4 2021 to $4.61 billion in Q1 2026 over the past five years.
- On a year-over-year basis, Current Assets has increased for 18 consecutive quarters, with growth averaging 16.4% over the last eight quarters.
- Peak year-over-year performance for Current Assets in the last five years was growth of 32.8% in Q1 2026, against a decline of 15.6% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $4.61 billion (Q1 2026), $3.95 billion (Q4 2025) and $3.85 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Biomarin Pharmaceutical | 11.51 Bn | 5.37 Bn | 786.91 Mn | 3.97 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.97 Bn |
| Mar 31, 2026 | 4.61 Bn |
| Dec 31, 2025 | 3.95 Bn |
| Sep 30, 2025 | 3.85 Bn |
| Jun 30, 2025 | 3.81 Bn |
| Mar 31, 2025 | 3.47 Bn |
| Dec 31, 2024 | 3.23 Bn |
| Sep 30, 2024 | 3.06 Bn |
| Jun 30, 2024 | 3.26 Bn |
| Mar 31, 2024 | 2.99 Bn |
| Dec 31, 2023 | 2.96 Bn |
| Sep 30, 2023 | 2.96 Bn |
| Jun 30, 2023 | 2.95 Bn |
| Mar 31, 2023 | 2.84 Bn |
| Dec 31, 2022 | 2.75 Bn |
| Sep 30, 2022 | 2.68 Bn |
| Jun 30, 2022 | 2.52 Bn |
| Mar 31, 2022 | 2.39 Bn |
| Dec 31, 2021 | 2.27 Bn |
| Sep 30, 2021 | 2.31 Bn |
API Access
Biomarin Pharmaceutical Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();